Skip to content

The Evaluation of the Toffee Mask for the Treatment of Obstructive Sleep Apnea

The Evaluation of the Toffee Mask for the Treatment of Obstructive Sleep Apnea

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03726346
Enrollment
39
Registered
2018-10-31
Start date
2018-11-26
Completion date
2019-11-13
Last updated
2022-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

This investigation is a prospective, non-randomized, non-blinded study. This investigation is designed to evaluate the performance, comfort and ease of use of the F&P Toffee mask amongst Obstructive Sleep Apnea (OSA) patients. Up to 45 OSA patients will be recruited from the Pulmonary Disease Specialists Research database.

Detailed description

Visit 1 will involve the participants being consented into the trial. Visit 2 will involve the participants being fitted with the F&P Toffee mask for use in home. The participant will then come in to return the mask (Visit Three) and have a final interview, this ensures the maximum time participants will be exposed to the Toffee mask in home will be 14 ± 4 days from visit two. The mask will be returned to the Institution at the conclusion of the trial and the participant will return to their previous mask. The Institution will recruit all patients within 2 weeks of the beginning of the study.

Interventions

Participants will be placed on this arm for a total of 14+- 4 days from visit 2. Participants will be using the Toffee mask during this treatment arm.

Sponsors

Fisher and Paykel Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult (22+ years of age) * Able to give informed consent * Apnea hypopnea Index (AHI) ≥ 5 on diagnostic night * Either prescribed Automatic positive airway pressure (APAP), Continuous positive airway pressure (CPAP) or Bi-level positive airway pressure (PAP) for OSA * Fluent in spoken and written English * Existing OSA mask user

Exclusion criteria

* Inability to give informed consent * Participant intolerant to PAP * Anatomical or physiological conditions making PAP therapy inappropriate * Current diagnosis of respiratory disease or carbon Dioxide (CO2) retention * Pregnant or may think they are pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Toffee Mask Acceptability14±4 days in homeParticipant preference for the Toffee mask over their usual mask. Determined from questionnaires -Subjective
Toffee Mask Comfort14±4 days in homeOverall Toffee mask comfort determined from questionnaires-Subjective
Toffee Mask Treatment Seal Performance-Subjective14±4 days in homeSealing performance of Toffee mask determined from questionnaires - Subjective

Secondary

MeasureTime frameDescription
Toffee Mask Treatment Performance-Objective14±4 days in homeObjective Apnea Hypopnea Index (AHI) data recorded from the participants Positive Airway Pressure (PAP) device and compared to baseline AHI data - Objective

Countries

United States

Participant flow

Participants by arm

ArmCount
Toffee Full Face Mask
Participants will be placed on this arm for a total of 14+- 4 days from visit 2. Participants will be using the Toffee mask during this treatment arm. Toffee Full Face Mask: Participants will be placed on this arm for a total of 14+- 4 days from visit 2. Participants will be using the Toffee mask during this treatment arm.
39
Total39

Baseline characteristics

CharacteristicToffee Full Face Mask
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
39 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
34 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Region of Enrollment
United States
39 Participants
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
24 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 39
other
Total, other adverse events
4 / 39
serious
Total, serious adverse events
0 / 39

Outcome results

Primary

Toffee Mask Acceptability

Participant preference for the Toffee mask over their usual mask. Determined from questionnaires -Subjective

Time frame: 14±4 days in home

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Toffee Full Face MaskToffee Mask AcceptabilityPreferred Toffee mask27 Participants
Toffee Full Face MaskToffee Mask AcceptabilityPreferred usual mask12 Participants
Primary

Toffee Mask Comfort

Overall Toffee mask comfort determined from questionnaires-Subjective

Time frame: 14±4 days in home

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Toffee Full Face MaskToffee Mask ComfortVery comfortable15 Participants
Toffee Full Face MaskToffee Mask ComfortComfortable17 Participants
Toffee Full Face MaskToffee Mask ComfortNeither comfortable nor uncomfortable3 Participants
Toffee Full Face MaskToffee Mask ComfortUncomfortable4 Participants
Toffee Full Face MaskToffee Mask ComfortVery uncomfortable0 Participants
Primary

Toffee Mask Treatment Seal Performance-Subjective

Sealing performance of Toffee mask determined from questionnaires - Subjective

Time frame: 14±4 days in home

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Toffee Full Face MaskToffee Mask Treatment Seal Performance-SubjectiveVery good14 Participants
Toffee Full Face MaskToffee Mask Treatment Seal Performance-SubjectiveGood14 Participants
Toffee Full Face MaskToffee Mask Treatment Seal Performance-SubjectiveNeither good nor poor9 Participants
Toffee Full Face MaskToffee Mask Treatment Seal Performance-SubjectivePoor2 Participants
Toffee Full Face MaskToffee Mask Treatment Seal Performance-SubjectiveVery poor0 Participants
Secondary

Toffee Mask Treatment Performance-Objective

Objective Apnea Hypopnea Index (AHI) data recorded from the participants Positive Airway Pressure (PAP) device and compared to baseline AHI data - Objective

Time frame: 14±4 days in home

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Toffee Full Face MaskToffee Mask Treatment Performance-ObjectiveAHI decreased19 Participants
Toffee Full Face MaskToffee Mask Treatment Performance-ObjectiveAHI increased10 Participants
Toffee Full Face MaskToffee Mask Treatment Performance-ObjectiveN/A10 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026